Article

Bringing innovation to rare disease patients in Europe

Johanna Friedl-Naderer, President, Europe, Canada & Partner Markets, Biogen on how collaboration between governments and industry can lead to better patient outcomes.

#Icare4Rare campaign launches to raise awareness ahead of Rare Disease Week 2021

To help raise awareness of rare disease, Reuters Events, Biogen and EU40 have collaborated to launch the #Icare4rare campaign to give promin...

Survey results: Accelerating digital transformation during COVID-19

View the results of a survey of over 1000 pharma executives on the impact COVID-19 has had and will have on their operations

A burning desire to make a difference for patients

Annexus Health, eyeforpharma’s 2020 Health Start-up winner is on a mission for patients

From reactive to predictive: Concerto’s new compositions

Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concert...

Access and Evidence

Latest Articles

Bringing innovation to rare disease patients in Europe

Izzy Gladstone, (Feb 17, 2021)

Johanna Friedl-Naderer, President, Europe, Canada & Partner Markets, Biogen on how collaboration between governments and industry can lead to better patient outcomes.
#Icare4Rare campaign launches to raise awareness ahead of Rare Disease Week 2021

Izzy Gladstone, (Feb 11, 2021)

To help raise awareness of rare disease, Reuters Events, Biogen and EU40 have collaborated to launch the #Icare4rare campaign to give prominence to Rare Disease Week 2021
Survey results: Accelerating digital transformation during COVID-19

Nicola Davies, (Sep 4, 2020)

View the results of a survey of over 1000 pharma executives on the impact COVID-19 has had and will have on their operations
A burning desire to make a difference for patients

Andrew Stone, (Apr 19, 2020)

Annexus Health, eyeforpharma’s 2020 Health Start-up winner is on a mission for patients
From reactive to predictive: Concerto’s new compositions

Andrew Stone, (Apr 10, 2020)

Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concerto HealthAI’s Jeff Elton
Evolving HTA frameworks to accelerate innovation

Andrew Stone, (Mar 14, 2020)

Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague
Can we afford to pay for future cures?

Ulrich Neumann, (Jan 24, 2020)

Medical innovation is racing ahead of healthcare’s ability to innovate on payments, but new ideas are emerging
Into pharma's roaring twenties

Paul Simms, (Jan 14, 2020)

A new decade is here. And despite the incredible science, pharma is ill-equipped.
Advancing RWE together with academia

Katie Osborne, (Jan 2, 2020)

Pharma can realise the potential of RWE faster by collaborating more effectively with academia but first it must build trust
Prescription drug pricing: The times they are a changin’

Ulrich Neumann, (Nov 25, 2019)

The political mood in the US on drug pricing at a national and state level is putting the pressure on pharma to demonstrate value

Columnists

Up close and personal: Reacting in a crisis - The Naji Gehchan story

Jill Donahue, (Mar 11, 2021)

This pharma leader worked in a war zone. Now he’s using the same tactics to navigate the pandemic

Up close and personal: A life of service - The Dr. Dirk Vander Mijnsbrugge story

Jill Donahue, (Oct 2, 2020)

Pfizer's Medical Affairs Lead, Rare Diseases, talks about purpose, patients and pharma's...

Up close and personal: The Thomas D’Hooghe story

Jill Donahue, (Apr 14, 2020)

Merck's Thomas D’Hooghe shares his thoughts on passion, purpose, leading people and making a...

eyeforpharma goes VIRTUAL

Izzy Gladstone, (Mar 26, 2020)

In light of the rapidly evolving impact of the COVID-19 virus, eyeforpharma has decided to turn...

eyeforpharma Awards: Recognizing and celebrating innovation

Paul Simms, (Dec 19, 2019)

Celebrating winners makes genuine innovation visible, setting the bar higher and broadening the...

Up Close and Personal: Emanuele Ostuni’s Story – Committed to delivering hope

Jill Donahue, (Sep 15, 2019)

Emanuele Ostuni has seen patients up close since he was a boy in southern Italy. He is now living...

The Jan Twomey story — Empowering and connecting

Jill Donahue, (Sep 6, 2019)

Up Close and Personal with Jan Twomey, MD, Medical Director, Takeda Oceania

Up Close and Personal - The Dr Sonal Bhatia Story

Jill Donahue, (Jul 25, 2019)

Read below to learn how a trip to India, a playdate and jewellery from Mexico all contributed to...

More Columns

Reuters Events | Pharma
Thought leadership and innovation for the Pharmaceutical Industry

Bringing innovation to rare disease patients in Europe

#Icare4Rare campaign launches to raise awareness ahead of Rare Disease Week 2021

Survey results: Accelerating digital transformation during COVID-19

A burning desire to make a difference for patients

From reactive to predictive: Concerto’s new compositions

Access and Evidence

Latest Articles

Bringing innovation to rare disease patients in Europe

#Icare4Rare campaign launches to raise awareness ahead of Rare Disease Week 2021

Survey results: Accelerating digital transformation during COVID-19

A burning desire to make a difference for patients

From reactive to predictive: Concerto’s new compositions

Evolving HTA frameworks to accelerate innovation

Can we afford to pay for future cures?

Into pharma's roaring twenties

Advancing RWE together with academia

Prescription drug pricing: The times they are a changin’

Columnists

How collaboration will strengthen the future of cell and gene therapies

How US pharma is charting a new course in a changed world

Redfining the role of the MSL in a changed world

Login

Access and Evidence

Latest Articles

Columnists